pharmaadvancement.com   Monthly E-newsletter - May 2020
 
cergentis
 
Newsletter on Pharma advancement
Pharma Advancment news letter subscribe Advertise with us
May 21 , 2020Ι Volume 5 I Pharma Advancement E-newsletter
  Pharma Advancement on LinkedIn Pharma Advancement on Facebook
Latest Updates
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Arcturus Therapeutics announced a partnership to support the expected manufacture of Arcturus COVID-19 mRNA vaccine candidate, intended to protect against the SARS-CoV-2 coronavirus.
Vaxart Announces Additional Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program
Vaxart Announces Additional Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program
AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand
AMRI Increases Hydroxychloro API Production in U.S. to Meet Potential COVID-19 Demand
MEDICAL FAIR ASIA 2020 postponed to 9 – 11 December 2020
MEDICAL FAIR ASIA 2020 postponed to 9 – 11 December 2020
Thailand LAB INTERNATIONAL 2020 postponed to October 2020
Thailand Lab International 2020 postponed to October 2020
CoVIg-19 Plasma Alliance: International Organizations Work on Globulin Therapy for COVID-19
CoVIg-19 Plasma Alliance: International Organizations Work on Globulin Therapy for COVID-19
Manufacturing Asia 2020 has been cancelled
Manufacturing Asia 2020 has been cancelled
Pharmapack expert recommends holistic approach to sustainability
Pharmapack expert recommends holistic approach to sustainability
CPhI & P-MEC China to host ‘Virtual Expo Connect’ in June
CPhI & P-MEC China to host Virtual Expo Connect in June
Advertise in Our Next Issue - Contact
E: marketing@pharmaadvancement.com
W: www.pharmaadvancement.com
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravirfor COVID-19 patients in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from India's drug regulator DCGI in late April. Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients...
View All Press Releases
Popular Events





9th Annual Publication and Clinical Trial Transparency 2020
2020-09-24 - 2020-08-25
Pullman Brussels Centre Midi , Belgium
W: https://informaconnect.com/publication/
Medical Fair Asia 2020
2020-12-09 - 2020-12-11
Marina Bay Sands , Singapore, Singapore
W: https://www.medicalfair-asia.com/
Digital Pathology & AI Congress USA
2020-11-19 - 2020-11-20
New York, USA
W: www.global-engage.com/digital-pathology/
CPhI China 2020
2020-12-16 - 2020-12-18
SNIEC , China
W: https://www.cphi-china.cn/cphi2020

BePharma 2020
2020-09-17 - 2020-09-19
Hilton Mexico City Reforma , Mexico
W: https://bepharma.org/
2020 Pharma CI USA Conference & Exhibition
2020-10-30 - 2020-12-01
Newark Liberty International Airport Marriott ,
NJ, USA
W: http://pharmaciconference.com/

pharmaadvancement.com

 

Editorial Inquiries

Advertising Inquiries
Untitled Document